Wąsik-Szczepanek E - Search Results

1

Outcome of SARS-CoV-2-Infected Polish Patients with Chronic Lymphocytic Leukemia.

Puła B, Pruszczyk K, Pietrusza E, Morawska M, Piszczek W, Kalicińska E, Szeremet A, Tryc-Szponder J, Wąsik-Szczepanek E, Drozd-Sokołowska J, Krzemień H, Rejus A, Gajewska M, Wiśniewski K, Wysocki M, Majeranowski A, Paszkiewicz-Kozik E, Steckiewicz P, Szukalski Ł, Bołkun Ł, Długosz-Danecka M, Giannopoulos K, Jamroziak K, Lech-Marańda E, Hus I. Puła B, et al. Among authors: wasik szczepanek e. Cancers (Basel). 2022 Jan 22;14(3):558. doi: 10.3390/cancers14030558. Cancers (Basel). 2022. PMID: 35158826 Free PMC article.

2

The clinical significance of ZAP-70 and CD38 expression in B-cell chronic lymphocytic leukaemia.

Hus I, Podhorecka M, Bojarska-Junak A, Roliński J, Schmitt M, Sieklucka M, Wasik-Szczepanek E, Dmoszyńska A. Hus I, et al. Ann Oncol. 2006 Apr;17(4):683-90. doi: 10.1093/annonc/mdj120. Epub 2006 Mar 8. Ann Oncol. 2006. PMID: 16524977 Free article.

3

ZAP-70 and CD38 expression are independent prognostic factors in patients with B-cell chronic lymphocytic leukaemia and combined analysis improves their predictive value.

Hus I, Bojarska-Junak A, Dmoszyńska A, Wasik-Szczepanek E, Sieklucka M, Trześniewska W, Glazer M, Roliński J. Hus I, et al. Folia Histochem Cytobiol. 2008;46(2):147-52. doi: 10.2478/v10042-008-0022-7. Folia Histochem Cytobiol. 2008. PMID: 18519230 Free article.

4

BAFF and APRIL expression in B-cell chronic lymphocytic leukemia: correlation with biological and clinical features.

Bojarska-Junak A, Hus I, Chocholska S, Wasik-Szczepanek E, Sieklucka M, Dmoszyńska A, Roliński J. Bojarska-Junak A, et al. Leuk Res. 2009 Oct;33(10):1319-27. doi: 10.1016/j.leukres.2009.03.030. Epub 2009 Apr 23. Leuk Res. 2009. PMID: 19395025

5

Thalidomide exerts distinct molecular antileukemic effects and combined thalidomide/fludarabine therapy is clinically effective in high-risk chronic lymphocytic leukemia.

Giannopoulos K, Dmoszynska A, Kowal M, Wasik-Szczepanek E, Bojarska-Junak A, Rolinski J, Döhner H, Stilgenbauer S, Bullinger L. Giannopoulos K, et al. Leukemia. 2009 Oct;23(10):1771-8. doi: 10.1038/leu.2009.98. Epub 2009 May 14. Leukemia. 2009. PMID: 19440214

6

Natural killer-like T CD3+/CD16+CD56+ cells in chronic lymphocytic leukemia: intracellular cytokine expression and relationship with clinical outcome.

Bojarska-Junak A, Hus I, Sieklucka M, Wasik-Szczepanek E, Mazurkiewicz T, Polak P, Dmoszynska A, Rolinski J. Bojarska-Junak A, et al. Oncol Rep. 2010 Sep;24(3):803-10. doi: 10.3892/or_00000924. Oncol Rep. 2010. PMID: 20664990

7

Assessment of the pathway of apoptosis involving PAR-4, DAXX and ZIPK proteins in CLL patients and its relationship with the principal prognostic factors.

Bojarska-Junak A, Sieklucka M, Hus I, Wąsik-Szczepanek E, Kusz ML, Surdacka A, Chocholska S, Dmoszyńska A, Roliński J. Bojarska-Junak A, et al. Folia Histochem Cytobiol. 2011;49(1):98-103. doi: 10.5603/fhc.2011.0014. Folia Histochem Cytobiol. 2011. PMID: 21526495 Free article.

8

Expression of circulating miRNAs associated with lymphocyte differentiation and activation in CLL-another piece in the puzzle.

Filip AA, Grenda A, Popek S, Koczkodaj D, Michalak-Wojnowska M, Budzyński M, Wąsik-Szczepanek E, Zmorzyński S, Karczmarczyk A, Giannopoulos K. Filip AA, et al. Ann Hematol. 2017 Jan;96(1):33-50. doi: 10.1007/s00277-016-2840-6. Epub 2016 Oct 12. Ann Hematol. 2017. PMID: 27730344 Free PMC article.

9

Efficacy and safety of the obinutuzumab-chlorambucil combination in the frontline treatment of elderly CLL patients with comorbidities - Polish Adult Leukemia Group (PALG) real-life analysis.

Długosz-Danecka M, Jurczak W, Łątka-Cabała E, Morawska M, Gawroński K, Wiśniewska A, Dudziński M, Wąsik-Szczepanek E, Chmielowska E, Łabędź A, Wdowiak K, Hus I. Długosz-Danecka M, et al. Pol Arch Intern Med. 2018 Aug 31;128(7-8):421-426. doi: 10.20452/pamw.4294. Epub 2018 Jul 11. Pol Arch Intern Med. 2018. PMID: 30057377 Free article.

10

Safety and Efficacy of Bendamustine Monotherapy in the First-Line Treatment of Patients with Chronic Lymphocytic Leukemia: Polish Lymphoma Research Group Real-Life Analysis.

Wołowiec D, Szymczyk A, Potoczek S, Krochmalczyk D, Zawirska D, Piotrowska M, Malenda A, Soroka-Wojtaszko M, Kopacz A, Wąsik-Szczepanek E, Graboś-Michalak J, Raźny M, Wichary R, Bramowicz-Jarosz B, Seweryn M, Długosz-Danecka M, Hus I. Wołowiec D, et al. Chemotherapy. 2019;64(3):155-162. doi: 10.1159/000503220. Epub 2019 Nov 12. Chemotherapy. 2019. PMID: 31715597

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

48 results

Search Page